Literature DB >> 9367374

Investigation of population diversity of human immunodeficiency virus type 1 in vivo by nucleotide sequencing and length polymorphism analysis of the V1/V2 hypervariable region of env.

E S Hughes1, J E Bell, P Simmonds.   

Abstract

In this study we have analysed variability in the V1 and V2 regions of human immunodeficiency virus type 1 (HIV-1) proviral sequences amplified from lymphoid tissue, brain and other non-lymphoid tissue collected at autopsy from three HIV-1-infected individuals with giant cell encephalitis. We found no evidence for any tissue-specific grouping of variants in the V1/V2 regions, in contrast to previous comparisons of sequences in the V3 region, but consistent with the existence of evolutionarily distinct lineages previously observed in these study subjects by sequence comparisons of the p17gag gene. Examination of inferred amino acid sequences from V1 and V2 revealed no correlations between tissue origin with overall charge, length or number of glycosylation sites. Length polymorphism analysis is a rapid method to compare whole populations of HIV-1 variants within a sample, and provides information on the length and diversity of the V1 and V2 hypervariable regions. Based upon a comparison of 42 individuals with CD4 counts ranging from 802 to < 1 at time of death, we found no evidence for changes in the length of V2 with development of AIDS. Using the number of length variants in the V1 and V2 hypervariable region as a marker of the overall degree of variability within HIV populations, we found no evidence for an increase or a decrease in diversity between those with and without AIDS defining illness.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9367374     DOI: 10.1099/0022-1317-78-11-2871

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  8 in total

1.  Genetic drift and within-host metapopulation dynamics of HIV-1 infection.

Authors:  S D Frost; M J Dumaurier; S Wain-Hobson; A J Brown
Journal:  Proc Natl Acad Sci U S A       Date:  2001-05-29       Impact factor: 11.205

2.  Variability in the human immunodeficiency virus type 1 gp120 Env protein linked to phenotype-associated changes in the V3 loop.

Authors:  Noah G Hoffman; Francoise Seillier-Moiseiwitsch; JaeHyung Ahn; Jason M Walker; Ronald Swanstrom
Journal:  J Virol       Date:  2002-04       Impact factor: 5.103

3.  HIVBrainSeqDB: a database of annotated HIV envelope sequences from brain and other anatomical sites.

Authors:  Alexander G Holman; Megan E Mefford; Niall O'Connor; Dana Gabuzda
Journal:  AIDS Res Ther       Date:  2010-12-14       Impact factor: 2.250

4.  Mosaic structure of the human immunodeficiency virus type 1 genome infecting lymphoid cells and the brain: evidence for frequent in vivo recombination events in the evolution of regional populations.

Authors:  A Morris; M Marsden; K Halcrow; E S Hughes; R P Brettle; J E Bell; P Simmonds
Journal:  J Virol       Date:  1999-10       Impact factor: 5.103

5.  Effects of human immunodeficiency virus encephalitis and drug abuse on the B lymphocyte population of the brain.

Authors:  Iain C Anthony; Dorothy H Crawford; Jeanne E Bell
Journal:  J Neurovirol       Date:  2004-06       Impact factor: 2.643

6.  Primary isolates of human immunodeficiency virus type 1 are usually dominated by the major variants found in blood.

Authors:  Yegor Voronin; Bhavna Chohan; Michael Emerman; Julie Overbaugh
Journal:  J Virol       Date:  2007-07-25       Impact factor: 5.103

7.  HIV-1 envelope subregion length variation during disease progression.

Authors:  Marcel E Curlin; Rafael Zioni; Stephen E Hawes; Yi Liu; Wenjie Deng; Geoffrey S Gottlieb; Tuofu Zhu; James I Mullins
Journal:  PLoS Pathog       Date:  2010-12-16       Impact factor: 6.823

8.  V3 loop truncations in HIV-1 envelope impart resistance to coreceptor inhibitors and enhanced sensitivity to neutralizing antibodies.

Authors:  Meg M Laakso; Fang-Hua Lee; Beth Haggarty; Caroline Agrawal; Katrina M Nolan; Mark Biscone; Josephine Romano; Andrea P O Jordan; George J Leslie; Eric G Meissner; Lishan Su; James A Hoxie; Robert W Doms
Journal:  PLoS Pathog       Date:  2007-08-24       Impact factor: 6.823

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.